Pfizer, Inc. (PFE) earnings
PFE earnings moved a median of +0.20% by the close. Quarterly and annual PFE reports and results, each read against the price at its own news timestamp. Back to the PFE overview →
33 measured PFE earnings events.
Where these PFE earnings landedvs 33 measured PFE earnings reactions
| Middle 50% of PFE earnings reactions | -0.52% to +1.56% |
|---|---|
| Median reaction (to close) | +0.20% |
| Measured reactions | 33 |
Point-in-time · zero look-ahead
Half of the 33 PFE earnings events with a measured close landed between -0.52% and +1.56%; 58% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Pfizer Declares Fourth-Quarter 2026 Dividend | Press release | +0.00% | -0.07% | |
| Form 10-Q PFIZER INC For: Jun 28 | SEC filing · Form 10-Q | +0.73% | +2.67% | |
| Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance | Press release | +0.73% | +2.67% | |
| Pfizer Declares Third-Quarter 2026 Dividend | Press release | -0.25% | -0.52% | |
| Form 10-Q PFIZER INC For: Mar 29 | SEC filing · Form 10-Q | -0.74% | -0.64% | |
| Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance | Press release | -0.74% | -0.64% | |
| Pfizer Declares Second-Quarter 2026 Dividend | Press release | +0.06% | -0.22% | |
| Form 10-K PFIZER INC For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.28% | |
| Pfizer Declares First-Quarter 2026 Dividend | Press release | +0.07% | +0.32% | |
| Form 10-Q PFIZER INC For: Sep 28 | SEC filing · Form 10-Q | +1.31% | -0.49% | |
| Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance | Press release | +1.31% | -0.49% | |
| Pfizer Declares Fourth-Quarter 2025 Dividend | Press release | +0.06% | -2.02% | |
| Form 10-Q PFIZER INC For: Jun 29 | SEC filing · Form 10-Q | +0.47% | +1.56% | |
| Pfizer Reports Strong Second-Quarter 2025 Results And Raises 2025 EPS Guidance | Press release | +0.47% | +1.56% | |
| Pfizer Declares Third-Quarter 2025 Dividend | Press release | +0.18% | -0.29% | |
| Form 10-Q PFIZER INC For: Mar 30 | SEC filing · Form 10-Q | -0.23% | -3.99% | |
| Pfizer Reports Solid First-Quarter 2025 Results And Reaffirms 2025 Guidance | Press release | +1.61% | +4.66% | |
| Pfizer Declares Second-Quarter 2025 Dividend | Press release | -0.20% | +1.70% | |
| Form 10-K PFIZER INC For: Dec 31 | SEC filing · Form 10-K | -0.17% | +1.26% | |
| Pfizer Declares First-Quarter 2025 Dividend | Press release | +0.32% | +0.91% | |
| Form 10-Q PFIZER INC For: Sep 29 | SEC filing · Form 10-Q | -0.33% | +0.97% | |
| Pfizer Reports Strong Third-Quarter 2024 Results And Raises 2024 Guidance | Press release | -0.81% | -1.90% | |
| Pfizer Declares Fourth-Quarter 2024 Dividend | Press release | -1.39% | -1.97% | |
| Form 10-Q PFIZER INC For: Jun 30 | SEC filing · Form 10-Q | +0.12% | +0.05% | |
| Pfizer Reports Strong Second-Quarter 2024 Results And Raises 2024 Guidance | Press release | +0.01% | +1.26% | |
| Pfizer Declares Third-Quarter 2024 Dividend | Press release | -0.40% | +1.57% | |
| Form 10-Q PFIZER INC For: Mar 31 | SEC filing · Form 10-Q | +0.14% | +0.14% | |
| Pfizer Reports First-Quarter 2024 Results | Press release | -0.23% | +3.15% | |
| Pfizer Declares Second-Quarter 2024 Dividend | Press release | +0.10% | -3.85% | |
| Form 10-K PFIZER INC For: Dec 31 | SEC filing · Form 10-K | +0.24% | +0.20% | |
| Pfizer Declares First-Quarter 2024 Dividend | Press release | +0.29% | +2.11% | |
| Form 10-Q PFIZER INC For: Oct 01 | SEC filing · Form 10-Q | -0.59% | -2.66% | |
| Pfizer Reports Third-Quarter 2023 Results | Press release | -0.36% | +0.20% |
Keep exploring
More PFE: analyst actions → · SEC filings → · PFE overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| RETROPHIN INC (RTRX) | 723 | +0.06% | 52% |
| IsoRay, Inc. (DE) (ISR) | 722 | -0.01% | 45% |
| ESSA Pharma Inc. (EPIX) | 718 | 0.00% | 38% |
| Tricida, Inc. (TCDA) | 715 | +0.06% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.